Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025:2961:145-154.
doi: 10.1007/978-1-0716-4722-6_9.

NMR-Based Quantification of GlycA and GlycB: Advancing Inflammatory Biomarkers in Clinical Diagnostics

Nieves Embade  1 , Oscar Millet  2
Affiliations

NMR-Based Quantification of GlycA and GlycB: Advancing Inflammatory Biomarkers in Clinical Diagnostics

Nieves Embade et al. Methods Mol Biol. 2025.

Abstract

GlycA and GlycB are composite proton 1H-NMR signals arising from the N-acetyl moieties of circulating acute-phase glycoproteins, chiefly α1-acid glycoprotein, α1-antichymotrypsin, haptoglobin, α1-antitrypsin, and transferrin. These signals have emerged as promising, noninvasive biomarkers of systemic inflammation and disease risk in a variety of clinical settings. Their quantification typically involves advanced NMR pulse sequences that enhance the separation of GlycA and GlycB from overlapping resonances and other interfering signals. Techniques such as CPMG (Carr-Purcell-Meiboom-Gill) spin-echo sequences are frequently used to suppress broad macromolecular backgrounds, while more specialized methods like DIfferential Relaxation (DIRE) and J-Edited Differential (JEDI) further refine the measurement of subtle spectral features. Elevated GlycA and GlycB levels have been linked to several inflammatory and cardiometabolic conditions, including cardiovascular disease, type 2 diabetes, rheumatoid arthritis, and obesity-related disorders. As their clinical utility continues to expand, standardized NMR-based protocols for GlycA and GlycB quantification offer a robust platform for identifying at-risk patients and monitoring disease progression or therapeutic efficacy.

Keywords: Biomarkers; GlycA; GlycB; Glycoproteins; Inflammation; Nuclear magnetic resonance (NMR).

PubMed Disclaimer

References

    1. Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315–335
    1. Qasba PK, Boeggeman E, Ramakrishnan B (2008) Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol Prog 24:520–526
    1. Wolfert MA, Boons GJ (2013) Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9:776–784
    1. He M, Zhou X, Wang X (2024) Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther 9:9. https://doi.org/10.1038/s41392-024-01886-1 - DOI
    1. Gornik O, Lauc G (2008) Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25:267–278

LinkOut - more resources